V. Randy White has been named CEO of Xenomics, a diagnostics firm developing tests utilizing transrenal nucleic acids as markers of disease. White previously served as CEO of Nanogen and in management positions at National Health Laboratories Holdings and American Medical Laboratories.
Lars Holmkvist has been appointed president of Applied Biosystems’ European Region. He will oversee and direct the group’s European operations, as well as its business in the Middle East and Africa. Holmkvist will report to Cathy Burzik, who recently took over for Michael Hunkapillar as president of ABI. He comes to ABI from Medtronic, where he served as vice president of vascular and cardiac surgery, Western Europe. Holmkvist also previously held executive positions at Pharmacia Hospital Care and was director of marketing for Becton Dickinson.
Accelrys has tapped William Taylor for the position of vice president of marketing. Taylor most recently served as the director of strategy and planning for the Rational division of IBM’s software group.
GE Healthcare Biosciences has named Peter Ehrenheim president of protein separations, a role he initially assumed for Amersham in 1999. Ehrenheim has served as vice president for North American manufacturing for Amersham Pharmacia Biotech. He holds an MSc in mechanical engineering from the Royal Institute of Technology in Stockholm, Sweden.
RxGen has appointed Steven Gullans its new president and CEO. He replaces the current interim CEO, Harry Penner, who will remain chairman of the CNS therapeutics firm. Prior to joining RxGen, Gullans served as chief scientific officer of US Genomics.